Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism
The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Abstract
Herein, we review the epitope approach to vaccine development, and discuss how knowledge of HLA supertypes might be used as a tool in the development of such vaccines. After reviewing the main structural features of the A2-, A3-, B7-, and B44- supertype alleles, and biological data demonstrating their immunological relevance, we analyze the frequency at which these supertype alleles are expressed in various ethnicities and discuss the relevance of those observations to vaccine development. Next, the existence of five new supertypes (A1, A24, B27, B58, and B62) is reported. As a result, it is possible to account for the predominance of all known HLA class I with only nine main functional binding specificities. The practical implications of this finding, as well as its relevance to understanding the functional implication of MHC polymorphism in humans, are discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Individual HLA-I alleles are classified into 12 discrete supertypes (52, 53), on the basis of similar peptide-anchor–binding specificities (26, 52, 53).”
From Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy (2018) · cites this paper as [52]
In the citing paper
“These supertypes together cover most HLA-A and HLA-B alleles found in distinct populations (52, 53).”
From Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy (2018) · cites this paper as [52]
Citations
Cites
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
Falk, K., Rötzschke, O., Stevanovié, S., Jung, G., & Rammensee, H.-G. (1991) · Nature · doi:10.1038/351290a0 · Cited by 2,411 · cited 5×
“Independent observations demonstrate that the motif of the mouse class I allele L is identical to the B7-supermotif (Corr et al. 1992; Falk et al. 1991) While the necessary task of fully exploring and cataloging MHC polymorphism continues, we have begun to appreciate the common denominators and similarities hidden wit…”
BackgroundInfluentialRosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Restifo, N. P., Dudley, M. E., Schwarz, S. L., Spiess, P. J., et al. (1998) · Nature Medicine · doi:10.1038/nm0398-321 · Cited by 1,784
MHC ligands and peptide motifs: first listing
Rammensee, H.-G., Friede, T., & Stevanović, S. (1995) · Immunogenetics · doi:10.1007/bf00172063 · Cited by 1,638
Borrow, P., Lewicki, H., Wei, X., Horwitz, M. S., Peffer, N., Meyers, H., Nelson, J. A., Gairin, J. E., Hahn, B. H., Oldstone, M. B. A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-205 · Cited by 1,183 · cited 4×
“…also allows focusing of immune responses against multiple conserved epitopes, a factor of crucial importance in the case of rapidly mutating pathogens, such as HIV and HCV (Borrow et al. 1997; Cooper et al. 1999; Goulder et al. 1997a, b; Nowak et al. 1995; Price et al. 1997; Weiner et al. 1995).”
BackgroundInfluentialGoulder, P. J. R., Phillips, R. E., Colbert, R. A., McAdam, S., Ogg, G., Nowak, M. A., Giangrande, P., Luzzi, G., Morgana, B., Edwards, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-212 · Cited by 1,116 · cited 1×
“…also allows focusing of immune responses against multiple conserved epitopes, a factor of crucial importance in the case of rapidly mutating pathogens, such as HIV and HCV (Borrow et al. 1997; Cooper et al. 1999; Goulder et al. 1997a, b; Nowak et al. 1995; Price et al. 1997; Weiner et al. 1995).”
BackgroundRefined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution
Saper, M. A., Bjorkman, P. J., & Wiley, D. C. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90567-p · Cited by 1,077 · cited 2×
“X-ray crystallographic analysis of MHC-peptide complexes revealed allele specific pockets within the peptide binding cleft of MHC molecules which accommodate specific peptide side chains (Fremont et al. 1992; Guo et al. 1992; Madden et al. 1992; Matsumura et al. 1992; Saper et al. 1991).”
BackgroundMethodThe Biochemistry and Cell Biology of Antigen Processing and Presentation
Germain, R. (1993) · Annual Review of Immunology · doi:10.1146/annurev.immunol.11.1.403 · Cited by 1,020 · cited 1×
“The complex of a major histocompatibilty complex (MHC) molecule and a peptidic antigen acts as the ligand recognized by MHC-restricted T cells (Garcia et al. 1999; Germain and Margulies 1993; Yewdell and Bennink 1999).”
BackgroundCrystal Structures of Two Viral Peptides in Complex with Murine MHC Class I H-2K b
Fremont, D. H., Matsumura, M., Stura, E. A., Peterson, P. A., & Wilson, L. A. (1992) · Science · doi:10.1126/science.1323877 · Cited by 861 · cited 1×
“X-ray crystallographic analysis of MHC-peptide complexes revealed allele specific pockets within the peptide binding cleft of MHC molecules which accommodate specific peptide side chains ( Fremont et al. 1992; Guo et al. 1992; Madden et al. 1992; Matsumura et al. 1992; Saper et al. 1991).”
BackgroundSette, A., Vitiello, A., Reherman, B., Fowler, P., Nayersina, R., Kast, W. M., Melief, C. J. M., Oseroff, C., Yuan, L., Ruppert, J., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.12.5586 · Cited by 830 · cited 1×
“…peptide-MHC binding have also been established (Engelhard 1994; Joyce and Natheson 1994; Sette and Grey 1992; Sidney et al. 1998), and the threshold of affinity associated with generation of immune responses has also been elucidated (Schaeffer et al. 1989; Sette et al. 1994; Southwood et al. 1998).”
BackgroundSelf-citationIdentification of self peptides bound to purified HLA-B27
Jardetzky, T. S., Lane, W. S., Robinson, R. A., Madden, D. R., & Wiley, D. C. (1991) · Nature · doi:10.1038/353326a0 · Cited by 827 · cited 5×
“Pool sequencing motifs for peptides bound to HLAB*1401-02, B*1503, B*1509, B*1510, B*1518, B*380102, B*3901, B*3902, B*3903-04, B*4801-02, B*7301, and B*2701-08 (Barber et al. 1996a, 1997; Boisgérault et al. 1996; DiBrino et al. 1994b; Falk et al. 1995c; Rötzschke et al. 1994; Garcia et al. 1997; Jardetzky et al. 1991…”
BackgroundInfluentialAnalysis of a Successful Immune Response against Hepatitis C Virus
Cooper, S., Erickson, A. L., Adams, E. J., Kansopon, J., Weiner, A. J., Chien, D. Y., Houghton, M., Parham, P., & Walker, C. M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80044-8 · Cited by 814 · cited 4×
“…also allows focusing of immune responses against multiple conserved epitopes, a factor of crucial importance in the case of rapidly mutating pathogens, such as HIV and HCV (Borrow et al. 1997; Cooper et al. 1999; Goulder et al. 1997a, b; Nowak et al. 1995; Price et al. 1997; Weiner et al. 1995).”
BackgroundInfluentialHUMAN CYTOTOXIC T LYMPHOCYTE RESPONSES TO EPSTEIN-BARR VIRUS INFECTION
Rickinson, A. B., & Moss, D. J. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.405 · Cited by 747 · cited 1×
“A similar motif has been inferred for two other alleles, A*2501 and A*3201, based upon published sequences of known epitopes (Harrer et al. 1996; Rickinson and Moss 1997; van Baalen et al. 1996) (Tables 1, 2).”
BackgroundHPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes
Hawley‐Nelson, P., Vousden, K. H., Hubbert, N. L., Lowy, D. R., & Schiller, J. T. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08570.x · Cited by 733 · cited 2×
“…to emphasize that the use of epitopes isolated from the context of the antigen of origin can overcome potential safety concerns, as exemplified by the case of the HPV E6 and E7 antigens whose expression is clearly associated with cervical carcinoma (Crook et al. 1989; Hawley-Nelson et al. 1989).”
BackgroundEmerging Principles for the Recognition of Peptide Antigens by MHC Class I Molecules
Matsumura, M., Fremont, D. H., Peterson, P. A., & Wilson, L. A. (1992) · Science · doi:10.1126/science.1323878 · Cited by 731 · cited 2×
“X-ray crystallographic analysis of MHC-peptide complexes revealed allele specific pockets within the peptide binding cleft of MHC molecules which accommodate specific peptide side chains (Fremont et al. 1992; Guo et al. 1992; Madden et al. 1992; Matsumura et al. 1992; Saper et al. 1991).”
BackgroundMethodPositive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection
Price, D. A., Goulder, P. J. R., Klenerman, P., Sewell, A. K., Easterbrook, P. J., Troop, M., Bangham, C. R. M., & Phillips, R. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1890 · Cited by 688 · cited 4×
“…also allows focusing of immune responses against multiple conserved epitopes, a factor of crucial importance in the case of rapidly mutating pathogens, such as HIV and HCV (Borrow et al. 1997; Cooper et al. 1999; Goulder et al. 1997a, b; Nowak et al. 1995; Price et al. 1997; Weiner et al. 1995).”
BackgroundInfluentialMadden, D. (1993) · Cell · doi:10.1016/0092-8674(93)90490-h · Cited by 675 · cited 2×
“For pocket analyses, the residues comprising the B and F pockets of HLA molecules described in crystallographic studies (Freemont et al. 1992; Guo et al. 1992; Madden et al. 1992, 1993; Matsumura et al. 1992; Saper et al. 1991) were compiled from the database of Parham and co-workers (1995).”
MethodSeveral Common HLA-DR Types Share Largely Overlapping Peptide Binding Repertoires
Southwood, S., Sidney, J., Kondo, A., del Guercio, M.-F., Appella, E., Hoffman, S., Kubo, R. T., Chesnut, R. W., Grey, H. M., & Sette, A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3363 · Cited by 665 · cited 1×
“…peptide-MHC binding have also been established (Engelhard 1994; Joyce and Natheson 1994; Sette and Grey 1992; Sidney et al. 1998), and the threshold of affinity associated with generation of immune responses has also been elucidated (Schaeffer et al. 1989; Sette et al. 1994; Southwood et al. 1998).”
BackgroundSelf-citationMissale, G., Bertoni, R., Lamonaca, V, Valli, A., Massari, M., Mori, C., Rumi, M. G., Houghton, M., Fiaccadori, F., & Ferrari, C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118842 · Cited by 658 · cited 1×
“The breadth of an immune response is thought to represent a crucial factor in control and /or resolution of HIV and HCV infection (Cooper et al. 1999; Couillin et al. 1994; McMichael and Phillips 1997; Missale et al. 1996).”
BackgroundMadden, D. R., Gorga, J. C., Strominger, J. L., & Wiley, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90252-8 · Cited by 656 · cited 2×
“X-ray crystallographic analysis of MHC-peptide complexes revealed allele specific pockets within the peptide binding cleft of MHC molecules which accommodate specific peptide side chains (Fremont et al. 1992; Guo et al. 1992; Madden et al. 1992; Matsumura et al. 1992; Saper et al. 1991).”
BackgroundMethodProminent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules
Ruppert, J., Sidney, J., Celis, E., Kubo, R. T., Grey, H. M., & Sette, A. (1993) · Cell · doi:10.1016/0092-8674(93)90472-3 · Cited by 628 · cited 2×
“Ruppert et al. 1993; 24.”
Self-citationParkhurst, M. R., Salgaller, M. L., Southwood, S., Robbins, P. F., Sette, A., Rosenberg, S. A., & Kawakami, Y. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.6.2539 · Cited by 556 · cited 3×
“For example a tumor epitope previously engineered for high HLA binding (Parkhurst et al. 1996) was effective for treatment of human melanoma when delivered in a mineral oil emulsion in the presence of IL2 (Rosenberg et al.”
BackgroundSelf-citationSTRUCTURAL BASIS OF T CELL RECOGNITION
Garcia, K. C., Teyton, L., & Wilson, I. A. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.369 · Cited by 523 · cited 3×
“The study of single amino acid substituted antigen analogs and the sequencing of endogenously bound, naturally processed peptides has identified critical residues required for allele-specific binding to MHC molecules (see, e.g., Engelhard 1994; Garcia et al. 1999; Sinigaglia and Hammer 1994).”
BackgroundDifferent length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle
Guo, H.-C., Jardetzky, T. S., Garrettt, T. P. J., Lane, W. S., Strominger, J. L., & Wiley, D. C. (1992) · Nature · doi:10.1038/360364a0 · Cited by 404 · cited 2×
“X-ray crystallographic analysis of MHC-peptide complexes revealed allele specific pockets within the peptide binding cleft of MHC molecules which accommodate specific peptide side chains (Fremont et al. 1992; Guo et al. 1992; Madden et al. 1992; Matsumura et al. 1992; Saper et al. 1991).”
BackgroundMethodSteven, N. M., Annels, N. E., Kumar, A., Leese, A. M., Kurilla, M. G., & Rickinson, A. B. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1605 · Cited by 350 · cited 1×
“One B18-restricted epitope (EBV 397–405, sequence DEVEFLGHY) has been reported in the literature (Steven et al. 1997), which suggests that the HLA molecules encoded by B*18 alleles may also share this specificity.”
ResultKast, W. M., Brandt, R. M. P., Sidney, J., Drijfhout, J. W., Kubo, R. T., Grey, H. M., Melief, C. J. M., & Sette, A. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.8.3904 · Cited by 345 · cited 1×
“Accordingly, the definition of class I and class II allele-specific MHC binding motifs allowed identification of regions within a protein that have the potential of binding particular MHC alleles (Engelhard 1994; Kast et al. 1994; Sette and Grey 1992; Sinigaglia and Hammer 1994).”
BackgroundSelf-citationWeiner, A., Erickson, A. L., Kansopon, J., Crawford, K., Muchmore, E., Hughes, A. L., Houghton, M., & Walker, C. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2755 · Cited by 334 · cited 4×
“…also allows focusing of immune responses against multiple conserved epitopes, a factor of crucial importance in the case of rapidly mutating pathogens, such as HIV and HCV (Borrow et al. 1997; Cooper et al. 1999; Goulder et al. 1997a, b; Nowak et al. 1995; Price et al. 1997; Weiner et al. 1995).”
BackgroundInfluentialESCAPE OF HUMAN IMMUNODEFICIENCY VIRUS FROM IMMUNE CONTROL
McMichael, A. J., & Phillips, R. E. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.271 · Cited by 323 · cited 1×
“The breadth of an immune response is thought to represent a crucial factor in control and /or resolution of HIV and HCV infection (Cooper et al. 1999; Couillin et al. 1994; McMichael and Phillips 1997; Missale et al. 1996).”
BackgroundAntigenic oscillations and shifting immunodominance in HIV-1 infections
Nowak, M. A., May, R. M., Phillips, R. E., Rowland-Jones, S., Lalloo, D. G., McAdam, S., Klenerman, P., Köppe, B., Sigmund, K., Bangham, C. R. M., et al. (1995) · Nature · doi:10.1038/375606a0 · Cited by 316 · cited 4×
“…also allows focusing of immune responses against multiple conserved epitopes, a factor of crucial importance in the case of rapidly mutating pathogens, such as HIV and HCV (Borrow et al. 1997; Cooper et al. 1999; Goulder et al. 1997a, b; Nowak et al. 1995; Price et al. 1997; Weiner et al. 1995).”
BackgroundInfluentialKoziel, M. J., Dudley, D., Afdhal, N., Grakoui, A., Rice, C. M., Choo, Q. L., Houghton, M., & Walker, B. D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118287 · Cited by 315 · cited 10×
“The Bpocket structure of A*3001 differs from that of A*2301 and A*2402 at 3 positions: F9, N66, and Q70.”
BackgroundInfluentialDefinition of specific peptide motifs for four major HLA-A alleles.
Kubo, R. T., Sette, A., Grey, H. M., Appella, E., Sakaguchi, K., Zhu, N. Z., Arnott, D., Sherman, N., Shabanowitz, J., Michel, H., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.8.3913 · Cited by 280 · cited 6×
“Furthermore, it is noted that the A*3001 B pocket matches that of A*0301, which accommodates a broad range of residues in position 2 of its peptide ligands (Kubo et al. 1994; Sidney et al. 1996a).”
BackgroundInfluentialSelf-citationThe Origins of HLA‐A,B,C Polymorphism
Parham, P., Adams, E. J., & Arnett, K. L. (1995) · Immunological Reviews · doi:10.1111/j.1600-065x.1995.tb00674.x · Cited by 264 · cited 2×
“All HLA-A and -B alleles identified through 1995 (Parham et al. 1995) were included.”
BackgroundPractical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs
Sidney, J., Grey, H. M., Kubo, R. T., & Sette, A. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80542-1 · Cited by 260
Self-citationTherapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines.
Mayordomo, J. I., Loftus, D. J., Sakamoto, H., De Cesare, C. M., Appasamy, P. M., Lotze, M. T., Storkus, W. J., Appella, E., & DeLeo, A. B. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1357 · Cited by 253 · cited 3×
“A variety of studies have also validated epitope-based vaccines as a strategy to address parasitic and microbial infections (Le et al. 1998; Wang et al. 1996), and cancer (Iwasaki et al. 1998; Mayordomo et al. 1996; Melief et al. 1996; Morgan et al. 1998; Vierboom et al. 1997).”
BackgroundMethodMorgan, D. J., Kreuwel, H. T. C., Fleck, S., Levitsky, H. I., Pardoll, D. M., & Sherman, L. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.643 · Cited by 244 · cited 1×
“A variety of studies have also validated epitope-based vaccines as a strategy to address parasitic and microbial infections (Le et al. 1998; Wang et al. 1996), and cancer (Iwasaki et al. 1998; Mayordomo et al. 1996; Melief et al. 1996; Morgan et al. 1998; Vierboom et al. 1997).”
BackgroundHLA supertypes and supermotifs: a functional perspective on HLA polymorphism
Sette, A., & Sidney, J. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80124-6 · Cited by 243 · cited 3×
“This work resulted in the definition of the B7-, A2- and B44-supertypes, which has been reviewed in detail elsewhere (Sette and Sidney 1998; Sidney et al. 1996b).”
BackgroundInfluentialSelf-citationSequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2
Parker, K. C., Bednarek, M. A., Hull, L. K., Utz, U., Cunningham, B., Zweerink, H. J., Biddison, W. E., & Coligan, J. E. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.11.3580 · Cited by 235 · cited 2×
“Parker et al. 1992; 25.”
Allen, T. M., Sidney, J., del Guercio, M.-F., Glickman, R. L., Lensmeyer, G. L., Wiebe, D. A., DeMars, R., Pauza, C. D., Johnson, R. P., Sette, A., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.6062 · Cited by 230 · cited 2×
“1996), macaques (Allen et al. 1998), and gorillas (Urvakes and co-workers, unpublished data).”
BackgroundSelf-citationKawashima, I., Hudson, S. J., Tsai, V., Southwood, S., Takesako, K., Appella, E., Sette, A., & Celis, E. (1998) · Human Immunology · doi:10.1016/s0198-8859(97)00255-3 · Cited by 229 · cited 3×
“Tcell recognition data in infectious diseases and cancer contexts, obtained in a number of different studies, further demonstrate that cross-reactive peptides are frequently recognized in the course of natural disease processes (Bertoletti et al. 1997; Bertoni et al. 1997; Doolan et al. 1997; Fleischhauer et al. 1996;…”
BackgroundSelf-citationCrook, T., Morgenstern, J. P., Crawford, L., & Banks, L. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03405.x · Cited by 221 · cited 2×
“…to emphasize that the use of epitopes isolated from the context of the antigen of origin can overcome potential safety concerns, as exemplified by the case of the HPV E6 and E7 antigens whose expression is clearly associated with cervical carcinoma (Crook et al. 1989; Hawley-Nelson et al. 1989).”
BackgroundTumor Eradication by Wild-type p53-specific Cytotoxic T Lymphocytes
Vierboom, M. P. M., Nijman, H. W., Offringa, R., Voort, E. I. H. V. D., Hall, T. V., Broek, L. V. D., Fleuren, G. J., Kenemans, P., Kast, W. M., & Melief, C. J. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.5.695 · Cited by 206 · cited 2×
“A variety of studies have also validated epitope-based vaccines as a strategy to address parasitic and microbial infections (Le et al. 1998; Wang et al. 1996), and cancer (Iwasaki et al. 1998; Mayordomo et al. 1996; Melief et al. 1996; Morgan et al. 1998; Vierboom et al. 1997).”
BackgroundBinding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype.
del Guercio, M. F., Sidney, J., Hermanson, G., Perez, C., Grey, H. M., Kubo, R. T., & Sette, A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.2.685 · Cited by 205 · cited 4×
“…a significant overlap in peptide binding repertoires was demonstrated amongst several serologically distinct HLA-B alleles (B*0702, B*3501, B*5101, B*5301, and B*5401 (Sidney et al. 1995, 1996c), and among different A2-subtypes (del Guercio et al. 1995; Fruci et al. 1993; Sidney et al. 1997).”
BackgroundInfluentialSelf-citationStructure of peptides associated with MHC class I molecules
Engelhard, V. H. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90028-0 · Cited by 200 · cited 4×
“The study of single amino acid substituted antigen analogs and the sequencing of endogenously bound, naturally processed peptides has identified critical residues required for allele-specific binding to MHC molecules (see, e.g., Engelhard 1994; Garcia et al. 1999; Sinigaglia and Hammer 1994).”
BackgroundInfluentialSidney, J., Grey, H. M., Southwood, S., Celis, E., Wentworth, P. A., del Guercio, M.-F., Kubo, R. T., Chesnut, R. W., & Sette, A. (1996) · Human Immunology · doi:10.1016/0198-8859(95)00173-5 · Cited by 195
Self-citationSeveral HLA alleles share overlapping peptide specificities.
Sidney, J., del Guercio, M. F., Southwood, S., Engelhard, V. H., Appella, E., Rammensee, H. G., Falk, K., Rötzschke, O., Takiguchi, M., Kubo, R. T., et al. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.1.247 · Cited by 194 · cited 5×
“Sidney et al. 1995; 13.”
BackgroundInfluentialSelf-citationDoolan, D. L., Hoffman, S. L., Southwood, S., Wentworth, P. A., Sidney, J., Chesnut, R. W., Keogh, E., Appella, E., Nutman, T. B., Lal, A. A., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80513-0 · Cited by 187 · cited 2×
“…that cross-reactive peptides are frequently recognized in the course of natural disease processes (Bertoletti et al. 1997; Bertoni et al. 1997; Doolan et al. 1997; Fleischhauer et al. 1996; Kawashima et al. 1998; Khanna et al. 1998; Threlkeld et al. 1997; Wang et al. 1998) and in the context…”
BackgroundSelf-citationvan der Most, R. G., Sette, A., Oseroff, C., Alexander, J., Murali-Krishna, K., Lau, L. L., Southwood, S., Sidney, J., Chesnut, R. W., Matloubian, M., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.12.5543 · Cited by 181 · cited 1×
“For example, vaccination with either dominant or subdominant epitopes has been shown to protect against acute or chronic viral infection in systems such as influenza or LCMV (An et al. 1997; Oukka et al. 1996; van der Most et al. 1996).”
BackgroundSelf-citationThe peptide-binding motif for the human transporter associated with antigen processing.
van Endert, P. M., Riganelli, D., Greco, G., Fleischhauer, K., Sidney, J., Sette, A., & Bach, J. F. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.6.1883 · Cited by 181
Self-citationPeptide-based, but not whole protein, vaccines elicit immunity to HER-2/neu, oncogenic self-protein
Disis, M. L., Gralow, J. R., Bernhard, H., Hand, S. L., Rubin, W. D., & Cheever, M. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.9.3151 · Cited by 179 · cited 1×
“Accessing subdominant specificities might be of particular value in the case of tumor antigens, where self-tolerance might have inactivated T cells recognizing the most dominant specificities (Disis et al. 1996; Feltkamp et al. 1995).”
BackgroundKhanna, R., Burrows, S. R., Nicholls, J., & Poulsen, L. M. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199802)28:02<451::aid-immu451>3.0.co;2-u · Cited by 178 · cited 2×
“Tcell recognition data in infectious diseases and cancer contexts, obtained in a number of different studies, further demonstrate that cross-reactive peptides are frequently recognized in the course of natural disease processes (Bertoletti et al. 1997; Bertoni et al. 1997; Doolan et al. 1997; Fleischhauer et al. 1996;…”
BackgroundTsai, V, Southwood, S., Sidney, J., Sakaguchi, K., Kawakami, Y., Appella, E., Sette, A., & Celis, E. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.4.1796 · Cited by 175 · cited 1×
“Furthermore, epitope based vaccines can also be analogued to increase potency and break tolerance, as highlighted by a number of different studies (Ahlers et al. 1997; Parkhurst et al. 1996; Sarobe et al. 1998; Tsai et al. 1997).”
BackgroundSelf-citationHuczko, E. L., Bodnar, W. M., Benjamin, D., Sakaguchi, K., Zhu, N. Z., Shabanowitz, J., Henderson, R. A., Appella, E., Hunt, D. F., & Engelhard, V. H. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2572 · Cited by 169 · cited 2×
“Huczko et al. 1993; 14.”
Feltkamp, M. C. W., Vreugdenhil, G. R., Vierboom, M. P. M., Ras, E., van der Burg, S. H., Schegget, J. T., Melief, C. J. M., & Kast, W. M. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250935 · Cited by 166 · cited 1×
“Accessing subdominant specificities might be of particular value in the case of tumor antigens, where self-tolerance might have inactivated T cells recognizing the most dominant specificities (Disis et al. 1996; Feltkamp et al. 1995).”
BackgroundIshioka, G. Y., Fikes, J., Hermanson, G., Livingston, B., Crimi, C., Qin, M., France del Guercio, M., Oseroff, C., Dahlberg, C., Alexander, J., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3915 · Cited by 164 · cited 2×
“These include not only a more potent response than that obtained by the use of whole antigens (Ishioka et al. 1999), but also control over qualitative aspects of the immune response.”
BackgroundSelf-citationBertoni, R., Sidney, J., Fowler, P., Chesnut, R. W., Chisari, F. V., & Sette, A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119559 · Cited by 162 · cited 2×
“Tcell recognition data in infectious diseases and cancer contexts, obtained in a number of different studies, further demonstrate that cross-reactive peptides are frequently recognized in the course of natural disease processes (Bertoletti et al. 1997; Bertoni et al. 1997; Doolan et al. 1997; Fleischhauer et al. 1996;…”
BackgroundSelf-citationSmith, K. J., Reid, S. W., Harlos, K., McMichael, A. J., Stuart, D. I., Bell, J. I., & Jones, E. Y. (1996) · Immunity · doi:10.1016/s1074-7613(00)80430-6 · Cited by 159
Smith, K. J., Reid, S. W., Stuart, D. I., McMichael, A. J., Jones, E. Y., & Bell, J. I. (1996) · Immunity · doi:10.1016/s1074-7613(00)80429-x · Cited by 156
Krausa, P., Brywka, M., Savage, D. A., Hui, K. M., Bunce, M., Ngai, J. L. F., Teo, D., Ong, Y. W., Barouch, D. H., Allsop, C. E. M., et al. (1995) · Tissue Antigens · doi:10.1111/j.1399-0039.1995.tb02444.x · Cited by 142 · cited 2×
“Population frequency data have been compiled from published sources (Fernandez-Viña et al. 1992; Imanishi et al. 1992; Krausa et al. 1995).”
MethodCorr, M., Boyd, L. F., Frankel, S. R., Kozlowski, S., Padlan, E. A., & Margulies, D. H. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1681 · Cited by 140 · cited 3×
“Independent observations demonstrate that the motif of the mouse class I allele Ld is identical to the B7-supermotif (Corr et al. 1992; Falk et al. 1991) While the necessary task of fully exploring and cataloging MHC polymorphism continues, we have begun to appreciate the common denominators and similarities hidden wi…”
BackgroundDiBrino, M., Tsuchida, T., Turner, R. V., Parker, K. C., Coligan, J. E., & Biddison, W. E. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.11.5930 · Cited by 139 · cited 6×
“DiBrino et al. 1993b; 2.”
BackgroundInfluentialDominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs
R�tzschke, O., Falk, K., Stevanović, S., Gnau, V., Jung, G., & Rammensee, H. (1994) · Immunogenetics · doi:10.1007/bf00171803 · Cited by 122
HLA-A2 subtypes are functionally distinct in peptide binding and presentation.
Barouch, D. H., Friede, T., Stevanović, S., Tussey, L., Smith, K. J., Rowland‐Jones, S., Braud, V. M., McMichael, A. J., & Rammensee, H. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.6.1847 · Cited by 113
Schaeffer, E. B., Sette, A., Johnson, D. L., Bekoff, M. C., Smith, J. A., Grey, H. M., & Buus, S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.12.4649 · Cited by 111 · cited 2×
“…peptide-MHC binding have also been established (Engelhard 1994; Joyce and Natheson 1994; Sette and Grey 1992; Sidney et al. 1998), and the threshold of affinity associated with generation of immune responses has also been elucidated (Schaeffer et al. 1989; Sette et al. 1994; Southwood et al. 1998).”
BackgroundSelf-citationDiBrino, M., Parker, K. C., Shiloach, J., Knierman, M. D., Lukszo, J., Turner, R. V., Biddison, W. E., & Coligan, J. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1508 · Cited by 109 · cited 6×
“DiBrino et al. 1993b; 2.”
BackgroundInfluentialWang, R., Johnston, S. L., Southwood, S., Sette, A., & Rosenberg, S. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.890 · Cited by 105 · cited 2×
“…et al. 1997; Bertoni et al. 1997; Doolan et al. 1997; Fleischhauer et al. 1996; Kawashima et al. 1998; Khanna et al. 1998; Threlkeld et al. 1997; Wang et al. 1998) and in the context of multiple HLA molecules, underlining the biological significance of the cross-reactivities detected by HLA…”
BackgroundSelf-citationSpecificity and degeneracy in peptide binding to HLA-B7-like class I molecules
Sidney, J., Southwood, S., del Guercio, M. F., Grey, H. M., Chesnut, R. W., Kubo, R. T., & Sette, A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3480 · Cited by 104
Self-citationCo‐evolution of human immunodeficiency virus and cytotoxic T‐lymphocyte responses
Goulder, P., Price, D., Nowak, M., Rowland‐Jones, S., Phillips, R., & McMichael, A. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb01004.x · Cited by 101
Threlkeld, S. C., Wentworth, P. A., Kalams, S. A., Wilkes, B. M., Ruhl, D. J., Keogh, E., Sidney, J., Southwood, S., Walker, B. D., & Sette, A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.4.1648 · Cited by 100 · cited 2×
“Tcell recognition data in infectious diseases and cancer contexts, obtained in a number of different studies, further demonstrate that cross-reactive peptides are frequently recognized in the course of natural disease processes (Bertoletti et al. 1997; Bertoni et al. 1997; Doolan et al. 1997; Fleischhauer et al. 1996;…”
BackgroundSelf-citationMelief, C. J. M. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80081-1 · Cited by 98
Barber, L. D., Percival, L., Valiante, N. M., Chen, L., Lee, C., Gumperz, J. E., Phillips, J. H., Lanier, L. L., Bigge, J. C., Parekh, R. B., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.2.735 · Cited by 96 · cited 14×
“Shaded residues indicates conformation with the putative supertype consensus pocket structure Table 5 F-pocket residues defining an HLA-A24-supertype Antigen Allele(s) C-terminus motif Reference(s)a F-pocket residuesb 77 80 81 116 A23 A*2301 WI 1–2 N I A Y A24 A*2402 FLI 3–5 N I A Y A30 A*3001 LYFM 6 D T L H A2 A*0201…”
BackgroundInfluentialWang, R., Charoenvit, Y., Corradin, G., De La Vega, P., Franke, E. D., & Hoffman, S. L. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.9.4061 · Cited by 95 · cited 2×
“A variety of studies have also validated epitope-based vaccines as a strategy to address parasitic and microbial infections (Le et al. 1998; Wang et al. 1996), and cancer (Iwasaki et al. 1998; Mayordomo et al. 1996; Melief et al. 1996; Morgan et al. 1998; Vierboom et al. 1997).”
BackgroundSarobe, P., Pendleton, C. D., Akatsuka, T., Lau, D., Engelhard, V. H., Feinstone, S. M., & Berzofsky, J. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3714 · Cited by 94 · cited 1×
“Furthermore, epitope based vaccines can also be analogued to increase potency and break tolerance, as highlighted by a number of different studies (Ahlers et al. 1997; Parkhurst et al. 1996; Sarobe et al. 1998; Tsai et al. 1997).”
BackgroundDifferences in MHC class I self peptide repertoires among HLA-A2 subtypes
Sudo, T., Kamikawaji, N., Kimura, A., Date, Y., Savoie, C. J., NAKASHIMA, H., Furuichi, E., Kuhara, S., & Sasazuki, T. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.10.4749 · Cited by 93
Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Behfet's disease
Falk, K., Rötzschke, O., Takiguchi, M., Gnau, V., Stevanović, S., Jung, G., & Rammensee, H. (1995) · International Immunology · doi:10.1093/intimm/7.2.223 · Cited by 92 · cited 7×
“…(D, E) residues in position 2, and hydrophobic residues at the C-terminus, noted in published pool sequencing motifs for B*3701, B*4402, B*4403, B60 (B*4001), and B61 (B*4006) (DiBrino et al. 1995; Falk et al. 1993, 1995a; Harris et al. 1993; Fleischhauer et al. 1994; Thorpe and Travers 1994).”
BackgroundInfluentialAn, L., & Whitton, J. L. (1997) · Journal of Virology · doi:10.1128/jvi.71.3.2292-2302.1997 · Cited by 90
Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes
Barber, L. D., Gillece-Castro, B. L., Percival, L., Li, X., Clayberger, C., & Parham, P. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00039-x · Cited by 90 · cited 14×
“Structurally, the B7-supertype molecules share a B pocket consensus motif of Y9, N63, I66, F/Y67, N/Q70, and Y99.”
BackgroundInfluentialBarber, L. D., Percival, L., Arnett, K. L., Gumperz, J. E., Chen, L., & Parham, P. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.4.1660 · Cited by 89 · cited 8×
“Barber et al. 1997; 21.”
BackgroundInfluentialAn HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins.
Zhang, Q. J., Gavioli, R., Klein, G., & Masucci, M. G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2217 · Cited by 89 · cited 1×
“Early studies defined the motifs recognized by some of the most common HLA types (DiBrino et al. 1993a, b; Falk et al. 1994; Kubo et al. 1994; Zhang et al. 1993).”
BackgroundDefining rules for the peptide-MHC class II interaction
Sinigaglia, F., & Hammer, J. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90033-7 · Cited by 86 · cited 2×
“The study of single amino acid substituted antigen analogs and the sequencing of endogenously bound, naturally processed peptides has identified critical residues required for allele-specific binding to MHC molecules (see, e.g., Engelhard 1994; Garcia et al. 1999; Sinigaglia and Hammer 1994).”
BackgroundProminent roles of secondary anchor residues in peptide binding to HLA-A24 human class I molecules
Kondo, A., Sidney, J., Southwood, S., del Guercio, M. F., Appella, E., Sakamoto, H., Celis, E., Grey, H. M., Chesnut, R. W., Kubo, R. T., et al. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.9.4307 · Cited by 85 · cited 3×
“Kondo et al. 1995; 6.”
BackgroundInfluentialSelf-citationPeptide motifs of HLA-A1,-A11,-A31, and-A33 molecules
Falk, K., Rötzschke, O., Takiguchi, M., Grahovac, B., Gnau, V., Stevanović, S., Jung, G., & Rammensee, H. (1994) · Immunogenetics · doi:10.1007/bf00167086 · Cited by 85
Endogenous peptides with distinct amino acid anchor residue motifs bind to HLA-A1 and HLA-B8.
DiBrino, M., Parker, K. C., Shiloach, J., Turner, R. V., Tsuchida, T., Garfield, M. K., Biddison, W. E., & Coligan, J. E. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.2.620 · Cited by 84 · cited 14×
“…B*1509, B*1510, B*1518, B*380102, B*3901, B*3902, B*3903-04, B*4801-02, B*7301, and B*2701-08 (Barber et al. 1996a, 1997; Boisgérault et al. 1996; DiBrino et al. 1994b; Falk et al. 1995c; Rötzschke et al. 1994; Garcia et al. 1997; Jardetzky et al. 1991) share positively charged (R, H, K)…”
BackgroundInfluentialDNA typing for HLA class I alleles: I. Subsets of HLA-A2 and of -A28
Fernández-Viña, M., Falco, M., Sun, Y., & Šťastný, P. (1992) · Human Immunology · doi:10.1016/0198-8859(92)90068-x · Cited by 82 · cited 2×
“Population frequency data have been compiled from published sources (Fernandez-Viña et al. 1992; Imanishi et al. 1992; Krausa et al. 1995).”
MethodPeptide motifs of closely related HLA class I molecules encompass substantial differences
Rötzschke, O., Falk, K., Stevanović, S., Jung, G., & Rammensee, H. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220940 · Cited by 82
Protection against lethal viral infection by vaccination with nonimmunodominant peptides
Oukka, M., Manuguerra, J. C., Livaditis, N., Tourdot, S., Riche, N., Vergnon, I., Cordopatis, P., & Kosmatopoulos, K. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.7.3039 · Cited by 81 · cited 2×
“For example, vaccination with either dominant or subdominant epitopes has been shown to protect against acute or chronic viral infection in systems such as influenza or LCMV (An et al. 1997; Oukka et al. 1996; van der Most et al. 1996).”
BackgroundHarrer, E. G., Harrer, T., Barbosa, P., Feinberg, M. B., Johnson, R. P., Buchbinder, S., & Walker, B. D. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.2.476 · Cited by 78 · cited 2×
“Harrer et al. 1996; 10.”
BackgroundBoisgérault, F., Khalil, I., Tieng, V., Connan, F., Tabary, T., Cohen, J. H. M., Choppin, J., Charron, D. J., & Toubert, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3466 · Cited by 76 · cited 3×
“…to HLAB*1401-02, B*1503, B*1509, B*1510, B*1518, B*380102, B*3901, B*3902, B*3903-04, B*4801-02, B*7301, and B*2701-08 (Barber et al. 1996a, 1997; Boisgérault et al. 1996; DiBrino et al. 1994b; Falk et al. 1995c; Rötzschke et al. 1994; Garcia et al. 1997; Jardetzky et al. 1991) share positively…”
BackgroundFleischhauer, K., Avila, D., Vilbois, F., Traversari, C., Bordignon, C., & Wallny, H. (1994) · Tissue Antigens · doi:10.1111/j.1399-0039.1994.tb02401.x · Cited by 75 · cited 4×
“Finally, the B44-supertype was defined on the basis of a shared specificity for peptides with negatively charged (D, E) residues in position 2, and hydrophobic residues at the C-terminus, noted in published pool sequencing motifs for B*3701, B*4402, B*4403, B60 (B*4001), and B61 (B*4006) (DiBrino et al. 1995; Falk et…”
BackgroundInfluentialPeptide motifs of HLA-A3, -A24, and -B7 molecules as determined by pool sequencing
Maier, R., Falk, K., Rötzschke, O., Maier, B., Gnau, V., Stevanović, S., Jung, G., Rammensee, H., & Meyerhans, A. (1994) · Immunogenetics · doi:10.1007/bf00189978 · Cited by 74
Enhanced immunogenicity of HIV-1 vaccine construct by modification of the native peptide sequence
Ahlers, J. D., Takeshita, T., Pendleton, C. D., & Berzofsky, J. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10856 · Cited by 74 · cited 1×
“Furthermore, epitope based vaccines can also be analogued to increase potency and break tolerance, as highlighted by a number of different studies (Ahlers et al. 1997; Parkhurst et al. 1996; Sarobe et al. 1998; Tsai et al. 1997).”
BackgroundDiBrino, M., Parker, K. C., Margulies, D. H., Shiloach, J., Turner, R. V., Biddison, W. E., & Coligan, J. E. (1995) · Biochemistry · doi:10.1021/bi00032a005 · Cited by 71 · cited 4×
“DiBrino et al. 1995; 20.”
BackgroundInfluentialPeptide motifs of HLA-B58, B60, B61, and B62 molecules
Falk, K., Rötzschke, O., Takiguchi, M., Gnau, V., Stevanović, S., Jung, G., & Rammensee, H. (1995) · Immunogenetics · doi:10.1007/bf00182333 · Cited by 69
Khanna, R., Burrows, S. R., Moss, D. J., & Silins, S. L. (1996) · Journal of Virology · doi:10.1128/jvi.70.8.5357-5362.1996 · Cited by 68 · cited 2×
“Khanna et al. 1996; 3.”
BackgroundLarge-scale production of class I bound peptides: assigning a signature to HLA-B * 1501
Prilliman, K. R., Lindsey, M., Zuo, Y., Jackson, K. W., Zhang, Y., & Hildebrand, W. H. (1997) · Immunogenetics · doi:10.1007/s002510050219 · Cited by 66 · cited 3×
“Residues within brackets are additional residues also predicted to be tolerated by multiple alleles within the putative supertype Falk et al. 1995a, b; Prilliman et al. 1997).”
BackgroundGarcı́a, F., Marina, A., & de Castro, J. A. L. (1997) · Tissue Antigens · doi:10.1111/j.1399-0039.1997.tb02741.x · Cited by 64 · cited 3×
“…B*7301, and B*2701-08 (Barber et al. 1996a, 1997; Boisgérault et al. 1996; DiBrino et al. 1994b; Falk et al. 1995c; Rötzschke et al. 1994; Garcia et al. 1997; Jardetzky et al. 1991) share positively charged (R, H, K) residues in position 2, and hydrophobic (A, L, I, V, M, Y, F, W)…”
BackgroundHaskó, G., Szabó, C., Németh, Z. H., Salzman, A. L., & Vizi, E. S. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199802)28:02<468::aid-immu468>3.0.co;2-z · Cited by 62
Bertoletti, A., Southwood, S., Chesnut, R. W., Sette, A., Falco, M., Ferrara, G. B., Penna, A., Boni, C., Fiaccadori, F., & Ferrari, C. I. (1997) · Hepatology · doi:10.1002/hep.510260435 · Cited by 59 · cited 2×
“…number of different studies, further demonstrate that cross-reactive peptides are frequently recognized in the course of natural disease processes (Bertoletti et al. 1997; Bertoni et al. 1997; Doolan et al. 1997; Fleischhauer et al. 1996; Kawashima et al. 1998; Khanna et al. 1998; Threlkeld et…”
BackgroundSelf-citationFleischhauer, K., Tanzarella, S., Wallny, H., Bordignon, C., & Traversari, C. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.2.787 · Cited by 54 · cited 2×
“Tcell recognition data in infectious diseases and cancer contexts, obtained in a number of different studies, further demonstrate that cross-reactive peptides are frequently recognized in the course of natural disease processes (Bertoletti et al. 1997; Bertoni et al. 1997; Doolan et al. 1997; Fleischhauer et al. 1996;…”
BackgroundDiBrino, M., Parker, K. C., Margulies, D. H., Shiloach, J., Turner, R. V., Biddison, W. E., & Coligan, J. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31652-1 · Cited by 52 · cited 14×
“…B*1509, B*1510, B*1518, B*380102, B*3901, B*3902, B*3903-04, B*4801-02, B*7301, and B*2701-08 (Barber et al. 1996a, 1997; Boisgérault et al. 1996; DiBrino et al. 1994b; Falk et al. 1995c; Rötzschke et al. 1994; Garcia et al. 1997; Jardetzky et al. 1991) share positively charged (R, H, K)…”
BackgroundInfluentialMethods to study peptides associated with MHC class I molecules
Joyce, S., & Nathenson, S. G. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90029-9 · Cited by 46
Kowalski, H., Erickson, A. L., Cooper, S., Domena, J. D., Parham, P., & Walker, C. M. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.4.1761 · Cited by 41 · cited 2×
“The relevance of this observation might well expand beyond the human species, as it has recently been noted that HLA-supertype specificities extend to chimpanzees (Bertoni et al. 1998; Kowalski et al. 1996), macaques (Allen et al. 1998), and gorillas (Urvakes and co-workers, unpublished data).”
BackgroundPeptide motifs of HLA-B38 and B39 molecules
Falk, K., Rötzschke, O., Takiguchi, M., Ganau, V., Stevanović, S., Jung, G., & Rammensee, H. (1995) · Immunogenetics · doi:10.1007/bf00182332 · Cited by 40
Goulder, P. (1997) · Immunology Letters · doi:10.1016/s0165-2478(97)86935-0 · Cited by 40
Chemistry of peptide interactions with MHC proteins
Sette, A., & Grey, H. M. (1992) · Current Opinion in Immunology · doi:10.1016/0952-7915(92)90130-7 · Cited by 38
Self-citationThe HLA-A0207 Peptide Binding Repertoire is Limited to a Subset of the A0201 Repertoire
Sidney, J., del Guercio, M., Southwood, S., Hermanson, G., Maewal, A., Appella, E., & Sette, A. (1997) · Human Immunology · doi:10.1016/s0198-8859(97)00206-1 · Cited by 37 · cited 3×
“…a significant overlap in peptide binding repertoires was demonstrated amongst several serologically distinct HLA-B alleles (B*0702, B*3501, B*5101, B*5301, and B*5401 (Sidney et al. 1995, 1996c), and among different A2-subtypes (del Guercio et al. 1995; Fruci et al. 1993; Sidney et al. 1997).”
BackgroundSelf-citationIwasaki, A., & Barber, B. H. (1998) · Cancer Immunology Immunotherapy · doi:10.1007/s002620050443 · Cited by 33
Two distinct HLA-A * 0101-specific submotifs illustrate alternative peptide binding modes
Kondo, A., Sidney, J., Southwood, S., del Guercio, M., Appella, E., Sakamoto, H., Grey, H. M., Celis, E., Chesnut, R. W., Kubo, R. T., et al. (1997) · Immunogenetics · doi:10.1007/s002510050200 · Cited by 31 · cited 13×
“Shaded residues indicates conformation with the putative supertype consensus pocket structure Table 5 F-pocket residues defining an HLA-A24-supertype Antigen Allele(s) C-terminus motif Reference(s)a F-pocket residuesb 77 80 81 116 A23 A*2301 WI 1–2 N I A Y A24 A*2402 FLI 3–5 N I A Y A30 A*3001 LYFM 6 D T L H A2 A*0201…”
BackgroundInfluentialSelf-citationHarris, P. E., Colovai, A. I., Liu, Z., Favera, R. D., & Suciu-Foca, N. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.11.5966 · Cited by 29 · cited 2×
“Finally, the B44-supertype was defined on the basis of a shared specificity for peptides with negatively charged (D, E) residues in position 2, and hydrophobic residues at the C-terminus, noted in published pool sequencing motifs for B*3701, B*4402, B*4403, B60 (B*4001), and B61 (B*4006) (DiBrino et al. 1995; Falk et…”
Backgroundvan Baalen, C. A., Klein, M. R., Huisman, R. C., Dings, M. E. M., Kerkhof‐Garde, S. R., Geretti, A. M., Gruters, R. A., van Els, C. A. C. M., Miedema, F. F., & Osterhaus, A. D. M. E. (1996) · Journal of General Virology · doi:10.1099/0022-1317-77-8-1659 · Cited by 25
Fruci, D., Rovero, P., Falasca, G., Chersi, A., Sorrentino, R., Butler, R. H., Tanigaki, N., & TOSI, R. M. (1993) · Human Immunology · doi:10.1016/0198-8859(93)90539-d · Cited by 22 · cited 3×
“Similarly, a significant overlap in peptide binding repertoires was demonstrated amongst several serologically distinct HLA-B alleles (B*0702, B*3501, B*5101, B*5301, and B*5401 (Sidney et al. 1995, 1996c), and among different A2-subtypes (del Guercio et al. 1995; Fruci et al. 1993; Sidney et al. 1997).”
BackgroundLe, T. P., Church, L. W. P., Corradin, G., Hunter, R. L., Charoenvit, Y., Wang, R., Vega, P. D. L., Sacci, J. B., Ballou, W. R., Kolodny, N., et al. (1998) · Vaccine · doi:10.1016/s0264-410x(97)00165-5 · Cited by 20 · cited 2×
“A variety of studies have also validated epitope-based vaccines as a strategy to address parasitic and microbial infections (Le et al. 1998; Wang et al. 1996), and cancer (Iwasaki et al. 1998; Mayordomo et al. 1996; Melief et al. 1996; Morgan et al. 1998; Vierboom et al. 1997).”
BackgroundIdentification of self peptides bound to purified HLA-B27
(1992) · Parasitology Today · doi:10.1016/0169-4758(92)90239-x · Cited by 20
HLA-A26 subtype A pockets accommodate acidic N-termini of ligands
Dumrese, T., Stevanović, S., Seeger, F. H., Yamada, N., Ishikawa, Y., Tokunaga, K., Takiguchi, M., & Rammensee, H. (1998) · Immunogenetics · doi:10.1007/s002510050443 · Cited by 18 · cited 14×
“Shaded residues indicates conformation with the putative supertype consensus pocket structure Table 5 F-pocket residues defining an HLA-A24-supertype Antigen Allele(s) C-terminus motif Reference(s)a F-pocket residuesb 77 80 81 116 A23 A*2301 WI 1–2 N I A Y A24 A*2402 FLI 3–5 N I A Y A30 A*3001 LYFM 6 D T L H A2 A*0201…”
BackgroundInfluentialThorpe, C. J., & Travers, P. (1994) · Immunogenetics · doi:10.1007/bf00189977 · Cited by 16
Characterization of the peptide‐binding specificity of HLA‐B*7301
Barber, L. D., Percival, L., & Parham, P. R. (1996) · Tissue Antigens · doi:10.1111/j.1399-0039.1996.tb02588.x · Cited by 9 · cited 15×
“Shaded residues indicates conformation with the putative supertype consensus pocket structure Table 5 F-pocket residues defining an HLA-A24-supertype Antigen Allele(s) C-terminus motif Reference(s)a F-pocket residuesb 77 80 81 116 A23 A*2301 WI 1–2 N I A Y A24 A*2402 FLI 3–5 N I A Y A30 A*3001 LYFM 6 D T L H A2 A*0201…”
BackgroundInfluentialChemistry of peptide interactions with MHC proteins
Sette, A., & Grey, H. M. (1992) · Current Biology · doi:10.1016/0960-9822(92)90508-8 · Cited by 3 · cited 4×
“Accordingly, the definition of class I and class II allele-specific MHC binding motifs allowed identification of regions within a protein that have the potential of binding particular MHC alleles (Engelhard 1994; Kast et al. 1994; Sette and Grey 1992; Sinigaglia and Hammer 1994).”
BackgroundInfluentialSelf-citationHeck's pictorial archive of military science, geography, and history
Heck, J. G. (1994) · Dover Publications eBooks · Cited by 1
Cited by
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Havel, J. J., Chowell, D., & Chan, T. A. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0116-x · Cited by 2,286
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
Chowell, D., Morris, L. G. T., Grigg, C. M., Weber, J. K., Samstein, R. M., Makarov, V., Kuo, F., Kendall, S. M., Requena, D., Riaz, N., et al. (2018) · Science · doi:10.1126/science.aao4572 · Cited by 1,142
Reliable prediction of T‐cell epitopes using neural networks with novel sequence representations
Nielsen, M., Lundegaard, C., Worning, P., Lauemøller, S. L., Lamberth, K., Buus, S., Brunak, S., & Lund, O. (2003) · Protein Science · doi:10.1110/ps.0239403 · Cited by 1,074
“All sequences from the database were downloaded and clustered into the nine super-types (A1, A2, A3, A24, B7, B27, B44, B58, and B62) and 3 outlier types (A29, B8, and B46) described by Sette and Sidney (1999).”
MethodHLA class I supertypes: a revised and updated classification
Sidney, J., Peters, B., Frahm, N., Brander, C., & Sette, A. (2008) · BMC Immunology · doi:10.1186/1471-2172-9-1 · Cited by 775
Self-citationNielsen, M., Lundegaard, C., Blicher, T., Lamberth, K., Harndahl, M., Justesen, S., Røder, G., Peters, B., Sette, A., Lund, O., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000796 · Cited by 719
“. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (A) Predictors of HLA-A locus molecules (with random negatives) Pan Self Neighbor Supertype Count A0101 0.46 0.88 0.26 A1101 A1 1213 A0201 0.87 0.89 0.82 A0206 A2 3876 A0202 0.81…”
BackgroundResultInfluentialSelf-citation
Metadata
- Authors
- Sette, A., & Sidney, J.
- ORCID
- Venue
- Immunogenetics
- Published
- 1999-11
- Volume
- 50
- Issue
- 3-4
- Pages
- 201-212
- ISSN
- 0093-7711 (ISSN-L)
- 1432-1211
- OpenAlex
- W2052321000
- Cited by
- 635
- References
- 115
- Citations by year
- 2026: 10 · 2025: 20 · 2024: 19 · 2023: 18 · 2022: 16 · 2021: 21 · 2020: 25 · 2019: 14 · 2018: 20 · 2017: 19 · 2016: 14 · 2015: 26 · 2014: 26 · 2013: 27 · 2012: 37
- FWCI
- 4.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Immunogenetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01ai045241-010, n01ai095362-000)
- National Institute of Allergy and Infectious Diseases (N01 AI-45241, N01-AI-95362)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- HLA-A, HLA-B, MHC polymorphism
- MeSH terms
- Alleles, Amino Acid Sequence, Animals, Epitopes, Humans, Molecular Sequence Data, Polymorphism, Genetic, HLA-A Antigens, HLA-B Antigens, Histocompatibility Antigens Class I
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.